Article
Treatment of chronic hepatitis C virus infection with crushed ledipasvir/sofosbuvir administered through a percutaneous endoscopic gastrostomy tube in a patient with HIV coinfection.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists - 1 Jan 2021
Huffman Vanessa, Andrade Diana C, Sherman Elizabeth, Niu Jianli, Eckardt Paula A
Abstract excerpt
PURPOSE: Ledipasvir/sofosbuvir is an oral combination therapy containing fixed doses of direct-acting antiviral agents indicated for the treatment of hepatitis C virus (HCV) infection. Currently there are limited data on the clinical efficacy of crushed ledipasvir/sofosbuvir administered via feeding tube. SUMMARY: This case report discusses the successful treatment of chronic HCV genotype 1b infection with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
